C-QUR Surgical Hernia Mesh Lawsuit
C-QUR hernia mesh is manufactured by Atrium Medical. It is comprised of a unique fish-oil based coating which has been linked to high rates of infection. In addition, C-QUR products have also resulted in serious side effects and complications similar to other troublesome products.
Products that may be involved in C-QUR lawsuits include:
- C-QUR Mesh
- C-QUR Mosaic
- C-QUR Tacshield
- C-QUR V-Patch
- C-QUR CentriFX
- C-QUR FX Mesh
In many cases, complications of a hernia mesh implant will require hernia revision surgery. Atrium Medical is facing over 2,500 C-QUR Surgical Hernia Mesh Lawsuits for injuries caused by the mesh devices.
C-QUR Hernia Mesh Complications
Surgical mesh is a medical device used to stabilize tissues during a hernia repair surgery. It was used in almost all hernia repair surgeries until recently, when experts began advising against its use due to the high number of adverse events associated with the mesh.
C-QUR mesh is manufactured by Atrium Medical and employs a unique coating of fish oil surrounding a plastic mesh. The fish-oil based coating was intended to be a bioabsorbable film which would keep the mesh from touching internal organs. Use of the coating was claimed to minimize tissue adherence to mesh which would reduce complications common with other mesh products.
Unfortunately, the introduction of the fish-oil coating may not have worked as intended and may also have introduced other complications. Though studies reportedly showed that the coated surgical mesh had a “minimal inflammatory response”, it may have caused allergic reaction, infection and inflammation which was not common with other products.
“In one case, the patient reported that a surgeon had to remove previously healthy tissue, including previously healthy muscle tissue, because of the damage done by the C-QUR mesh, with the patient subsequently developing a life-threatening infection requiring prolonged hospitalization.”
Injuries and complications of C-QUR hernia mesh have included:
- Severe pain
- Abdominal infection
- Fistula formation
- Allergic reaction
- Mesh migration
- Bowel adhesion
- Bowel obstruction
- Intestinal or organ perforation
- Hernia recurrence
- Revision surgery to remove and/or repair
Instead of reducing inflammation, it may have resulted in a significant increase in immune response and adhesions around the mesh implants, caused by inflammatory response.
C-QUR Hernia Mesh Recalls and FDA Involvement
Atrium Medical has been subject to a number of complaints and warnings involving the U.S. Food and Drug Administration (FDA), beginning in 2008.
Atrium’s manufacturing facilities were subject to FDA inspection four times from 2009 to 2013, resulting in warning letters being issued in 2009, 2010 and 2013. The Agency cited manufacturing conditions, sterility and product defects and in 2013, the FDA and the U.S. Department of Justice worked to block Atrium manufacturing. The company later agreed to pay $6 million to settle issues included in the injunction.
Also in 2013, Atrium voluntarily recalled 145,000 C-QUR products including lots of C-QUR V-Patch, TacShield, Edge and other C-QUR mesh. The recall was issued over packaging concerns which may have exposed the products to high humidity for long periods of time, causing product to stick to the inner sleeve of packaging.
Despite FDA concerns and recalls, C-QUR products continue to be marketed and used in hernia repair surgery.
Atrium Medical C-QUR Surgical Hernia Mesh Lawsuits
Atrium Medical is facing over 2,500 federal lawsuits for injuries caused by versions of the C-QUR Surgical Hernia Mesh devices, as well as others filed in state and local courts. Federal lawsuits have been consolidated into multi-district litigation (MDL 2753) in the U.S. District Court for the District of New Hampshire.
The first bellwether case for the C-QUR hernia mesh lawsuits was scheduled to be heard February of 2020. The court date was delayed due to the COVID-19 pandemic until July 2021; however the first case was reported to have been settled out-of-court. The second bellwether trial date has not been set, leading some to speculate that a settlement may be under consideration. No settlement offer has been announced.
People who received a C-QUR Atrium Medical Surgical Hernia Mesh implant and have expected complications or required revision surgery, may be eligible for compensation.